-- Hisamitsu Pharmaceutical's (TYO:4530) profit attributable to owners of the parent fell 12% to 19.2 billion yen for the fiscal year ended Feb. 28 from 21.8 billion yen a year earlier.
The pharmaceutical group's earnings per share declined to 268.22 yen from 295.15 yen a year ago, according to a Tokyo bourse filing on Monday.
Net sales rose 4.5% to over 163 billion yen from 156 billion yen in the prior year.
For the fiscal year ending Feb. 28, 2027, the company does not provide an earnings forecast due to its scheduled delisting on May 11.
Hisamitsu Pharmaceutical plans to pay no dividends for the current fiscal year, which is lower than the 90 yen per share paid in the year-ago period.